Calidi Biotherapeutics Stock (AMEX: CLDI) stock price, news, charts, stock research, profile.
Open | $1.45 |
Close | $1.13 |
Volume / Avg. | 526.05K / 278.93K |
Day Range | $1.01 - $1.49 |
52 Wk Range | 1.41 - 50.00 |
Market Cap | $11.64M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 29 |
Short Interest | 9% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Calidi Biotherapeutics (AMEX:CLDI) through any online brokerage.
Other companies in Calidi Biotherapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Galecto (NASDAQ:GLTO), Monopar Therapeutics (NASDAQ:MNPR), Can Fite Biofarma (AMEX:CANF) and BioRestorative Therapies (NASDAQ:BRTX).
Calidi Biotherapeutics has a consensus price target of $1.67.
The stock price for Calidi Biotherapeutics (AMEX: CLDI) is $ last updated .
There are no upcoming dividends for Calidi Biotherapeutics.
Calidi Biotherapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Calidi Biotherapeutics.
Calidi Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.